APRIL SILVERBERG: Open Payments
NPI 1659912749 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,219 in 62 payments from 15 companies in 2025. Trend: 2023 $199 · 2024 $851 · 2025 $1,219
Food & beverage: $1,219
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $210 |
| ABBVIE INC. | 10 | $197 |
| Regeneron Healthcare Solutions, Inc. | 7 | $176 |
| UCB, Inc. | 6 | $158 |
| Amgen Inc. | 5 | $95 |
| Arcutis Biotherapeutics, Inc. | 4 | $85 |
| Galderma Laboratories, L.P. | 3 | $85 |
| GENZYME CORPORATION | 2 | $59 |
| Botanix SB Inc | 2 | $36 |
| Cipher Pharmaceuticals US LLC | 1 | $25 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, Bimzelx, OTEZLA, Zoryve, SOFDRA, Natroba.
Industry payments across FL — which companies pay providers there.
